Executive Director, Ningbo Hospital, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Specializes in: Minimally invasive treatment of malignant tumors such as irreversible electroporation ablation, comprehensive treatment of advanced gastrointestinal tumors and respiratory tract tumors, tumor nutritional support, cancer pain management, and other palliative tumor treatments. Scientific Research Achievements: Has successively presided over and participated as a key member in 15 projects including the National Natural Science Foundation of China (Key Program), Provincial Natural Science Foundation, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and interdisciplinary projects, National Institute of Health and Medicine (Hefei) Seed Fund, Zhejiang University Young Faculty Fund, Provincial Department of Education Research Projects, and Provincial Health Science and Technology Development Projects. As a major contributor, has published 30 papers, participated in the compilation of 2 monographs, and holds 3 invention patents. Research Directions: Has long been engaged in interdisciplinary tumor research, particularly artificial intelligence research and development for minimally invasive tumor ablation therapy; research and development of novel anti-tumor drugs; clinical research on palliative tumor treatments such as nutrition and cancer pain. Personal Honors: Received First Prize for Outstanding Case at the 7th National Congress on Cancer Rehabilitation and Palliative Medicine (2009), Third Prize for Outstanding Paper from the Chinese Society of Clinical Oncology Scientific Fund (2011), Second Prize for Science and Technology Progress from the Ministry of Education (2019), Commendation from the Organization Department of the Shanghai Municipal Committee and Shanghai Municipal Education Commission (2021), Outstanding Communist Party Member of Renji Hospital (2022), Outstanding Employee Commendation of Renji Hospital (2023).